These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9300618)

  • 1. Psychopharmacological distinction between novel full-efficacy "D1-like" dopamine receptor agonists.
    Deveney AM; Waddington JL
    Pharmacol Biochem Behav; 1997 Oct; 58(2):551-8. PubMed ID: 9300618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
    Daly SA; Waddington JL
    Psychopharmacology (Berl); 1993; 113(1):45-50. PubMed ID: 7862827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
    Daly SA; Waddington JL
    Br J Pharmacol; 1994 Nov; 113(3):839-44. PubMed ID: 7858875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
    Deveney AM; Waddington JL
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
    Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
    Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
    Smith HP; Nichols DE; Mailman RB; Lawler CP
    Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R; Kull B; Wahlestedt C; Salmi P
    Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
    Salmi P; Ahlenius S
    Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
    Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
    Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats.
    Steele TD; Hodges DB; Levesque TR; Locke KW
    Pharmacol Biochem Behav; 1997 Oct; 58(2):477-83. PubMed ID: 9300608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.
    Clifford JJ; Tighe O; Croke DT; Kinsella A; Sibley DR; Drago J; Waddington JL
    Neuroscience; 1999; 93(4):1483-9. PubMed ID: 10501473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrexidine--the first full dopamine D1 receptor agonist.
    Salmi P; Isacson R; Kull B
    CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach.
    Clifford JJ; Waddington JL
    Psychopharmacology (Berl); 1998 Apr; 136(3):284-90. PubMed ID: 9566814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
    Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington JL; Koshikawa N
    Eur J Pharmacol; 1999 Feb; 367(2-3):143-9. PubMed ID: 10078986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethological resolution of behavioral topography and D2-like vs. D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions.
    O'Sullivan GJ; Kinsella A; Grandy DK; Tighe O; Croke DT; Waddington JL
    Synapse; 2006 Feb; 59(2):107-18. PubMed ID: 16320306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
    Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
    J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.